#United States #New York #Monteverde #Merger #Kronos Bio

Investigation into the Merger of Kronos Bio, Inc.

On May 1, 2025, Monteverde & Associates PC, a recognized class action law firm based in New York City, announced an inquiry into the proposed merger of Kronos Bio, Inc. (NASDAQ: KRON) with Concentra Biosciences, LLC. The firm aims to protect the interests of shareholders amid this significant corporate transition.

Details of the Proposed Merger

The merger agreement stipulates that Concentra will acquire Kronos Bio for a cash payment of $0.57 per share of common stock, along with a non-tradeable contingent value right. This acquisition presents a crucial moment for shareholders, as the approximate valuation of Kronos Bio will be assessed, and it is imperative for stakeholders to ensure they receive fair compensation for their investments.

Monteverde & Associates is known for recovering millions for shareholders and is listed among the Top 50 Firms in 2024’s ISS Securities Class Action Services Report. This firm has built a strong reputation for its capabilities in handling complex securities litigation and pursuing justice for investors.

The Importance of Investigation

The investigation aims to determine whether Kronos Bio’s board of directors acted legally and in the best interests of its shareholders in approving this merger. Investors are encouraged to reflect on the deal's merits, and whether they have been adequately compensated in the proposed transaction.

Thomas Monteverde, the firm’s founder, stated, "No company should compromise the rights of its shareholders. We are here to ensure that every investor gets a fair deal."

What Should Shareholders Do?

Shareholders who own common stock of Kronos Bio and have concerns about the merger are urged to reach out. The inquiry is thorough and holds no initial cost for shareholders, underlining the firm’s commitment to protecting investor rights. Additionally, engaging with a law firm that focuses on class actions can be pivotal for investors navigating this potentially transformative phase for the firm.

Interested parties can contact Juan Monteverde, Esq. directly via email or telephone presenting their inquiries or expressing their desire to learn more about their rights and the pending merger.

Contact Information

For further information, Kronos Bio shareholders can connect with Monteverde & Associates PC:

• - Address: The Empire State Building, 350 Fifth Ave, Suite 4740, New York, NY 10118, USA
• - Email: [email protected]
• - Phone: (212) 971-1341

Monteverde & Associates will provide free consultations to help shareholders understand their rights and any potential legal recourse they may have in relation to the merger.

Legal Disclaimer

As with any legal matter, potential outcomes can vary, and previous results do not guarantee future results. Shareholders are encouraged to act swiftly and stay informed about the developments surrounding the merger as well as their rights during this investigative period.